These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 2515230)
1. [Study of the prophylactic effect of ubenimex on experimental pyelonephritis induced by Pseudomonas in neutropenic mice]. Tanaka N; Kumamoto Y; Hirose T; Yokoo A Kansenshogaku Zasshi; 1989 Jul; 63(7):748-56. PubMed ID: 2515230 [TBL] [Abstract][Full Text] [Related]
2. [Study of the prophylactic and therapeutic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by pseudomonas aeruginosa in neutropenic mice]. Tanaka N; Kumamoto Y; Hirose T; Yokoo A Kansenshogaku Zasshi; 1989 Feb; 63(2):145-55. PubMed ID: 2473150 [TBL] [Abstract][Full Text] [Related]
3. [Study of the effect of combination therapy of human granulocyte-colony stimulating factor (G-CSF) and amikacin on experimental pyelonephritis induced by Pseudomonas aeruginosa in neutropenic mice]. Tanaka N; Kumamoto Y; Hirose T; Yokoo A Kansenshogaku Zasshi; 1990 Aug; 64(8):994-1003. PubMed ID: 1698897 [TBL] [Abstract][Full Text] [Related]
4. [Study of the prophylactic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by Pseudomonas aeruginosa in diabetic mice]. Yokoo A; Kumamoto Y; Hirose T; Tanaka N Kansenshogaku Zasshi; 1989 Jul; 63(7):738-47. PubMed ID: 2482317 [TBL] [Abstract][Full Text] [Related]
5. Enhancement by ubenimex (bestatin) of host resistance to Candida albicans infection. Aoyagi K; Itoh N; Abe F; Abe S; Uchida K; Ishizuka M; Takeuchi T; Yamaguchi H J Antibiot (Tokyo); 1992 Nov; 45(11):1778-84. PubMed ID: 1468987 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of host resistance to opportunistic infections by ubenimex (bestatin). Ishizuka M; Abe F; Abe S; Uchida K; Ikeda T; Ito N; Aoyagi K; Yamaguchi H; Takeuchi T Adv Exp Med Biol; 1992; 319():193-200. PubMed ID: 1414594 [TBL] [Abstract][Full Text] [Related]
7. Therapy of neutropenic rats infected with Pseudomonas aeruginosa. Lumish RM; Norden CW J Infect Dis; 1976 May; 133(5):538-47. PubMed ID: 816976 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial resistance induced by recombinant interleukin 1 in myelosuppressed mice: effect of treatment schedule and correlation with colony-stimulating activity in the bloodstream. Campanile F; Binaglia L; Boraschi D; Tagliabue A; Fioretti MC; Puccetti P Cell Immunol; 1990 Jun; 128(1):250-60. PubMed ID: 2111738 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice. Fu KP; Hetzel N; Gregory FJ; Hung PP J Antimicrob Chemother; 1987 Oct; 20(4):541-6. PubMed ID: 3680089 [TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia. Ziegler EJ; Douglas H J Infect Dis; 1979 Mar; 139(3):288-96. PubMed ID: 109545 [TBL] [Abstract][Full Text] [Related]
11. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host. Pennington JE; Small GJ J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484 [TBL] [Abstract][Full Text] [Related]
12. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts. Babalola CP; Nightingale CH; Nicolau DP J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727 [TBL] [Abstract][Full Text] [Related]
13. The effect of ubenimex on N-methyl-N'-nitro-N-nitrosoguanidine-induced stomach tumor in rats. Ebihara K; Abe F; Yamashita T; Shibuya K; Hayashi E; Takahashi K; Horinishi H; Enomoto M; Ishizuka M; Umezawa H J Antibiot (Tokyo); 1986 Jul; 39(7):966-70. PubMed ID: 3759651 [TBL] [Abstract][Full Text] [Related]
14. Ubenimex treatment in congenital cyclic neutropenia. Aihara M; Sasaki K; Yoshida Y Tohoku J Exp Med; 1990 Jun; 161(2):85-90. PubMed ID: 2264063 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of interleukin 1 and interleukin 2 releases by ubenimex. Shibuya K; Hayashi E; Abe F; Takahashi K; Horinishi H; Ishizuka M; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1987 Mar; 40(3):363-9. PubMed ID: 3494719 [TBL] [Abstract][Full Text] [Related]